Previous close | 0.6700 |
Open | 2.6000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 22.50 |
Expiry date | 2024-05-17 |
Day's range | 0.6000 - 2.6000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Comprehensive Analysis of ARWR's Fiscal 2024 Q2 Earnings Against Market Forecasts
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript May 9, 2024 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.01634 EPS, expectations were $-0.06. Arrowhead Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and […]
PASADENA, Calif., May 09, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 second quarter ended March 31, 2024. The Company is hosting a conference call today, May 9, 2024, at 4:30 p.m. ET to discuss the results.